Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1).
Saved in:
| Title: | Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1). |
|---|---|
| Authors: | Daudén, Esteban1 (AUTHOR) estebandauden@gmail.com, de la Cueva, Pablo2 (AUTHOR), Salgado-Boquete, Laura3 (AUTHOR), Llamas-Velasco, Mar1 (AUTHOR), Fonseca, Eduardo4 (AUTHOR), Pau-Charles, Ignasi5 (AUTHOR), Asensio, David5 (AUTHOR), Guilà, Meritxell5 (AUTHOR), Carrascosa, José Manuel6 (AUTHOR), DIMESKIN 1 Study investigators (AUTHOR), Linares, Mario (AUTHOR), Vélez, Antonio (AUTHOR), Yébenes, Mireia (AUTHOR), Mollet, Jordi (AUTHOR), Gardeazabal, Jesús (AUTHOR), Flórez, Ángeles (AUTHOR), Suárez, José (AUTHOR), Armesto, Susana (AUTHOR), Fernández, Almudena (AUTHOR), Ruiz, José Carlos (AUTHOR) |
| Source: | Dermatology & Therapy. Jan2023, Vol. 13 Issue 1, p329-345. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-022-00863-2 |
